Genes that code for current therapeutic targets for migraines, such as calcitonin gene-related peptide (CGRP) (CALCA/CALCB) and serotonin 1F receptor, are among the new risk loci identified for the disease (HTR1F) [85]. Here, CALCA is linked to migraine disorder.